single-shot vaccine
The Latest
-
Woman Dies From Rare Johnson & Johnson COVID-19 Vaccine Complication
The woman was diagnosed to have died of thrombosis with thrombocytopenia syndrome (TTS). 
The woman was diagnosed to have died of thrombosis with thrombocytopenia syndrome (TTS). -
Moderna And Novavax Working On One-Shot Flu And COVID-19 Combo Vaccine
Moderna and Novavax are separately developer single-shot vaccines that will be effective against both COVID-19 and the flu. 
Moderna and Novavax are separately developer single-shot vaccines that will be effective against both COVID-19 and the flu. -
Johnson & Johnson HIV Vaccine Fails To Lower Infection
Today, almost 39 million people worldwide have HIV. 
Today, almost 39 million people worldwide have HIV. -
FDA Grants Emergency Approval To Johnson & Johnson's COVID-19 Vaccine
Around 4 million doses of the new vaccine should be made available next week. 
Around 4 million doses of the new vaccine should be made available next week. -
Johnson & Johnson Kicks Off Two-Shot Test Of Potential COVID Vaccine
The trial seeks to enroll around 30,000 patients, with a one-dose test involving as many as 60,000 participants. 
The trial seeks to enroll around 30,000 patients, with a one-dose test involving as many as 60,000 participants. -
Johnson & Johnson COVID Vaccine Trials Halted By Patient's Illness
Johnson & Johnson said that such pauses, done in compliance with regulatory policies, are normal in major clinical tests, which can comprise tens of thousands of participants. 
Johnson & Johnson said that such pauses, done in compliance with regulatory policies, are normal in major clinical tests, which can comprise tens of thousands of participants. -
Johnson & Johnson Tests Single-Shot COVID Vaccine In 60,000 People
Dr. Anthony Fauci, the leading infectious disease expert in the U.S., says Johnson & Johnson's final trial might generate results as early as December. 
Dr. Anthony Fauci, the leading infectious disease expert in the U.S., says Johnson & Johnson's final trial might generate results as early as December.
